Confirmed Three-Year Rfs And Os Of The Randomized Trial Of Adjuvant S-1 Versus S-1 Plus Docetaxel After Curative Resection Of Pstage Iii Gastric Cancer (Jaccro Gc-07).

Kazuhiro Yoshida,Yasuhiro Kodera,Mitsugu Kochi,Takeshi Sano,Yoshihiro Kakeji,Wataru Ichikawa,Shintaro Kurahashi,Hironori Yamaguchi,Takahiro Toyokawa,Masato Nakamura,Kazumasa Fujitani,Yoshinari Mochizuki,Mitsuhiko Ota,Jun Hihara,Yoichi Makari,Atsushi Takeno,Masahiro Takeuchi,Masashi Fujii

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 3|浏览0

暂无评分

摘要

159Background: JACCRO GC-07 is a randomized controlled trial to explore postoperative S-1/docetaxel compared to S-1 alone after D2 gastrectomy for pStage III gastric cancer (GC) patients. The secon...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要